Age associations with tacrolimus and mycophenolic acid pharmacokinetics in stable Black and White kidney transplant recipients: Implications for health inequities

Author:

Tornatore Kathleen M.12ORCID,Attwood Kristopher3,Venuto Rocco C.24,Murray Brian24

Affiliation:

1. Transplantation Immunosuppressive Pharmacology Research Program, Translational Pharmacology Research Core, Department of Pharmacy Practice School of Pharmacy and Pharmaceutical Sciences University at Buffalo Buffalo New York USA

2. Department of Medicine, School of Medicine and Biomedical Sciences University at Buffalo Buffalo New York USA

3. Department of Biostatistics, School of Public Health and Health Professions University at Buffalo Buffalo New York USA

4. Division of Nephrology, Erie County Medical Center University at Buffalo Buffalo New York USA

Abstract

AbstractTacrolimus (TAC) and mycophenolic acid (MPA) provide maintenance immunosuppression and is dosed empirically in elderly kidney transplant recipients (KTRs) resulting in health inequities. Limited immunosuppressive pharmacokinetics are available comparing adult ages. This secondary analysis compared TAC and MPA pharmacokinetics and adverse effects (AEs) among young, middle‐aged, and elderly Black and White KTRs. The 12‐h TAC and MPA pharmacokinetics with AE evaluation were conducted in 67 stable KTRs greater than or equal to 6 months post‐transplant. TAC regimens were adjusted to target troughs. MPA regimens were adjusted using clinical response. Participants were: young: less than or equal to 40 years; middle age: greater than 40 to 60 years, and elderly greater than 60 years. Noncompartmental pharmacokinetic analysis determined area under the concentration‐time curve 0–12 h (AUC0‐12h), clearance (CL), and CL/body mass index (BMI) with 0‐h troughs. MPA enterohepatic recirculation (EHR), MPA‐AUC6‐12h/MPA‐AUC0‐12h, and MPA glucuronide (MPAG)‐AUC0‐12h/MPA‐AUC0‐12h were determined. Univariate analysis of variance (ANOVA) was conducted using SAS version 9.4. No group differences were noted for estimated glomerular filtration rate, MPA, and TAC doses. EHR was reduced in elderly with decreased MPA‐AUC6‐12h/MPA‐AUC0‐12h (p = 0.049) and increased MPAG‐AUC0‐12h/MPA‐AUC0‐12h (p = 0.036). MPA troughs (p = 0.045) were reduced in the elderly. TAC CL/BMI (p = 0.043) was reduced in the elderly. For therapeutic MPA AUC0‐12h: 30–60 mg·h/L, 34.3% KTRs achieved this target with 55.2% greater than the therapeutic range. 77.6% KTR were in the TAC AUC0‐12h target: 100–190 ng·h/mL and 19.4% were below this range with no age relationship. In 44% young, 26% middle‐age and 7.8% elderly subjects achieved target AUC0‐12h for both medications (p = 0.036). Neurologic AEs were manifested in the elderly (p = 0.014). Immunosuppressive pharmacokinetics demonstrated age‐related differences with reduced TAC CL/BMI and MPA EHR and increased neurologic AE in the elderly. This immunosuppressive regimen may require age‐adjusted individualization to optimize allograft function.

Publisher

Wiley

Subject

General Pharmacology, Toxicology and Pharmaceutics,General Biochemistry, Genetics and Molecular Biology,General Medicine,General Neuroscience

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3